Slide background
A Unique Model to Accelerate Industry-sponsored Research in Malaysia
The influx of industry-sponsored research (ISR) into the Asia Pacific region is continually growing due to the rising costs and complicated processes involved in drug development. Several countries within the region...
Read More
Malaysia Collaborates with Two Prominent Singapore Organisations to Advance Clinical Research (VIDEO)
Clinical Research Malaysia (CRM) inked two Memorandum of Understanding (MoU) with two prominent Singapore organizations in the field of clinical research. This will further pave the way for better Malaysia–Singapore collaborations in advancing drug development and research capabilities between both countries.
Read More
Research Personality: Dato' Dr Mahiran Mustafa
I am actively involved as a coordinator for Technical Working Group for National Antimicrobial Action Plan. I am also the Chairperson for Clinical Practice Guidelines: Management of Dengue Infection in Adults where we train health providers on dengue management.
Read More
Hospital Raja Perempuan Zainab II
Featuring HRPZII as our Featured Site in the latest CRM Bulletin Issue 16. Find out more about the site!
Read More
Download the latest CRM Bulletin Issue 16, Available Now!
CRM Bulletin Issue 16: "Tackling Infectious Disease" is out, download your copy today!
Read More
Slide background
Malaysia Pharma Report 2018
Through exclusive interviews with the Malaysian Minister of Health as well as the head of the country’s regulatory body – the NPRA – this report examines emerging trends in Malaysian healthcare, with Prime Minister Matahir Mohamad spearheading a bold health policy reform.
Read More
CRM Becomes First Southeast Asia Research Organisation to Join IQVIA’s Global EPON
Clinical Research Malaysia (CRM) today signed a memorandum of understanding (MoU) to establish a strategic alliance with IQVIA’s global Early Phase Oncology Network (EPON). The agreement makes Clinical Research Centre at Sarawak General Hospital the first in Southeast Asia to be part of IQVIA’s prestigious network of globally qualified Phase I oncology sites.
Read More

We have come far in 2018 as highlighted by Dr Akhmal and we strive for more this year.

Watch Dr Akhmal Yusof’s 2019 New Year Message Video

CRM’s Customer Satisfactory Survey

At Clinical Research Malaysia, we value your feedback to make sure our services are up to the highest standards. We’d love to hear your experience with us. Take our 3-minute survey so we can continue to improve.

More than 120

CRM Study Coordinators Nationwide

32 Million

Multi-ethnic Population in Malaysia

In The News

Live Feed



Cardiovascular disease and oncology are the top therapeutic areas of ISR conducted in 2018. Read more on Malaysia's ISR statistics for 2018 here:

On 21 Sep 2018, We published an article on "Evolution of Clinical Trial Agreement Review in Malaysia Through CRM" available on Applied Clinical Trials written by Nurul Atiqah Abd Rahman & Norafizaa Yusop from CRM Legal Department team.

Read more here:

Load More...

About Us

Established by Malaysian Ministry of Health in 2012, Clinical Research Malaysia exists to advance global health solutions for a brighter, more hopeful future for the people by providing speedy and reliable end-to-end clinical research support for quality studies.

The development of Malaysia’s first Phase I Clinical Trial Guideline marks an important milestone in the history of clinical research in Malaysia. This guideline is part of a much bigger initiative of the Phase I Realization Project (P1RP) that aims to build a complete and comprehensive early phase clinical research ecosystem in the country. Inpouring of early phase studies presents multiple socioeconomic advantages and these include transfer of knowledge and technologies, inflow of investments, better healthcare infrastructure and increased economic activity.

Understanding Clinical Trials

A clinical trial is an investigation of the effectiveness and safety of a new or improved medicine / treatment / medical device. Clinical trials are an extremely vital process in advancing medical care and treatment. Carefully conducted clinical trials are the safest and fastest way to find treatments that work.



We are committed to continually improve our services to meet the expectations of the clinical research industry players, regulatory agencies and other stakeholders in our effort to build a globally trusted research organization.

Watch Our Video

Supported by


MyMedR (Malaysian Medical Repository) is an open access collection of Malaysian health and biomedical research. The materials are imported from PubMed and MyJurnal. Users can use this search engine to search for Malaysian researchers and their publications.

This is a research collaboration between University of Malaya, International Medical University and Ministry of Health. It is funded by the Academy of Family Physicians of Malaysia.

Subscribe to CRM bulletin